From GlobeNewswire:

Travere Therapeutics, Inc. announced that Eric Dube, Ph.D., President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 3:45 p.m. PT. A live webcast will be accessible on the company’s website. Travere Therapeutics is a biopharmaceutical company focused on developing life-changing therapies for rare diseases. For more information, visit travere.com. A replay of the presentation will be available for up to 30 days following the event.



Read more: Travere Therapeutics to Present at the 42nd Annual J.P.